Friday, September 23, 2022

Aadi Biosciences Finds $72.5M In Private Placement

Los Angeles-based Aadio Biosciences, a public biopharmaceutical company focused on therapy for cancer, said on Thursday that it has raised $72.5M in a private placement equity financing. The company said it agreed to issue and sell an aggregate of 3,373,526 shares of its common stock at a price of $12.50 per share, and pre-funded warrants to purchase up

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.